(2021) WHO Coronavirus (COVID-19) Dashboard. covid19.who.int. Accessed 25 May 2021.
(2021) Coronavírus Brasil. covid.saude.gov.br/. Accessed 24 May 2021.
Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet Lond Engl. 2020;395:1014–5.
CDC. (2020) COVID-19 and Your Health. In: Cent. Dis. Control Prev. www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed 25 May 2021.
de Siqueira JVV, Almeida LG, Zica BO, Brum IB, Barceló A, de Siqueira Galil AG. Impact of obesity on hospitalizations and mortality, due to COVID-19: a systematic review. Obes Res Clin Pract. 2020. doi.org/10.1016/j.orcp.2020.07.005.
Michalakis K, Panagiotou G, Ilias I, Pazaitou-Panayiotou K. Obesity and COVID-19: a jigsaw puzzle with still missing pieces. Clin Obes. 2021;11:e12420.
Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, Wang Y. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020;99:47–56.
IBGE. Pesquisa Nacional de Saúde: 2019: Atenção primária à saúde e informações antropométricas: Brasil. Volume 66. Rio de Janeiro: IBGE, Coordenação de Trabalho e Rendimento; 2020.
Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006;13:203–10.
Rottoli M, Bernante P, Belvedere A, et al. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single italian centre. Eur J Endocrinol. 2020;183:389–97.
Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021;37:e3377.
Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med. 2020;19:100283.
World Health Organization. (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. 252–252.
The Sex., Gender and COVID-19 Project | Global Health 50/50.
Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11:29.
Meng Y, Wu P, Lu W, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLOS Pathog. 2020;16:e1008520.
Qin L, Li X, Shi J, et al. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan. J Med Virol. 2020;92:2684–92.
Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–81.
Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, Liu S, Yang J-K. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.
Clayton JA, Tannenbaum C. Reporting sex, gender, or both in Clinical Research? JAMA. 2016;316:1863.
Klein SL, Dhakal S, Ursin RL, Deshpande S, Sandberg K, Mauvais-Jarvis F. Biological sex impacts COVID-19 outcomes. PLOS Pathog. 2020;16:e1008570.
Marôco J. Análise de Equações Estruturais: Fundamentos teóricos, software & Aplicações. Lda: ReportNumber; 2014.
Hoyle RH. (2012) Path analysis and structural equation modeling with latent variables. In: Cooper H, Camic PM, Long DL, Panter AT, Rindskopf D, Sher KJ, editors APA Handb. Res. Methods Psychol. Vol 2 Res. Des. Quant. Qual. Neuropsychol. Biol. American Psychological Association, Washington, pp 333–367.
Brasil, Secretaria de Vigilância em Saúde. (2021) Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica: emergência de saúde pública de importância nacional pela doença pelo coronavírus 2019 – covid-19.
(2021) SRAG 2020 - Banco de Dados de Síndrome Respiratória Aguda Grave - incluindo dados da COVID-19 - Open Data. opendatasus.saude.gov.br/dataset/bd-srag-2020. Accessed 25 May 2021.
Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and gender equity in Research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev. 2016;1:2.
Brasil, Secretaria de Vigilancia em Saúde, SIVEP Gripe - SISTEMA DE INFORMAÇÃO DE VIGILÂNCIA EPIDEMIOLÓGICA DA GRIPE FICHA DE REGISTRO INDIVIDUAL. (2021) Ficha de Notificação da Vigilância da Síndrome Respiratória Aguda Grave (SRAG) no Brasil. - CASOS DE SÍNDROME RESPIRATÓRIA AGUDA GRAVE HOSPITALIZADO- 27/07/2020.
Kline RB. (2011) Principles and practice of structural equation modeling, 3rd ed. xvi, 427.
Standards Committee AS for BS. Guidelines for reporting results in bariatric surgery. Obes Surg. 1997;7:521–2.
Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, Southern WN, Mantzoros CS. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262.
Discacciati MG, Siani S, Campa A, Nakaya HI. Why should obese youth be prioritized in COVID-19 vaccination programs? A nationwide retrospective study. Lancet Reg Health - Am. 2022;7:100167.
Hallak J, Teixeira TA, Barrozo LV, Singer J, Kallas EG, Saldiva PH. Male sex rather than socioeconomic vulnerability as a determinant for COVID-19 death in Sao Paulo: a population-based study. SAGE Open Med. 2022;10:205031212211055.
Nunes BP, de Souza ASS, Nogueira J, de Andrade FB, Thumé E, Teixeira DSdaC, Lima-Costa MF, Facchini LA, Batista SR. Multimorbidity and population at risk for severe COVID-19 in the brazilian longitudinal study of aging. Cad Saúde Pública. 2020. doi.org/10.1590/0102-311X00129620.
Harris MB, Walters LC, Waschull S. Gender and ethnic differences in obesity-related behaviors and attitudes in a College Sample. J Appl Soc Psychol. 1991;21:1545–66.
Rahman M, Williams G, Al Mamun A. Gender differences in hypertension awareness, antihypertensive use and blood pressure control in bangladeshi adults: findings from a national cross-sectional survey. J Health Popul Nutr. 2017;36:23.
Nimgaonkar I, Valeri L, Susser E, Hussain S, Sunderram J, Aviv A. The age pattern of the male-to-female ratio in mortality from COVID-19 mirrors that of cardiovascular disease in the general population. Aging. 2021;13:3190–201.
Bae S, Kim SR, Kim M-N, Shim WJ, Park S-M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021;107:373–80.
de Souza FSH, Hojo-Souza NS, Batista BD, de O, Silva CM, Guidoni DL. On the analysis of mortality risk factors for hospitalized COVID-19 patients: a data-driven study using the major brazilian database. PLoS ONE. 2021;16:e0248580.
Kim L, Garg S, O’Halloran A, et al. Risk factors for Intensive Care Unit Admission and In-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated hospitalization Surveillance Network (COVID-NET). Clin Infect Dis. 2021;72:e206–14.
Magalhães BK, Queiroz F, Salomão MLM, de Godoy MF. The impact of chronic cardiovascular disease on COVID-19 clinical course. J Clin Transl Res. 2022;8:308–22.
Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.
Tadic M, Saeed S, Grassi G, Taddei S, Mancia G, Cuspidi C. Hypertension and COVID-19: ongoing controversies. Front Cardiovasc Med. 2021;8:639222.
Haji Aghajani M, Asadpoordezaki Z, Haghighi M, Pourhoseingoli A, Taherpour N, Toloui A, Sistanizad M. Effect of underlying Cardiovascular Disease on the prognosis of COVID-19 patients; a sex and age-dependent analysis. Arch Acad Emerg Med. 2021;9:e65.
Parra-Bracamonte GM, Lopez-Villalobos N, Parra-Bracamonte FE. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico. Ann Epidemiol. 2020;52:93–98e2.
Poly TN, Islam MdM, Yang HC, Lin MC, Jian W-S, Hsu M-H, Jack Li Y-C. Obesity and mortality among patients diagnosed with COVID-19: a systematic review and Meta-analysis. Front Med. 2021. doi.org/10.3389/fmed.2021.620044.
Seidu S, Gillies C, Zaccardi F, Kunutsor SK, Hartmann-Boyce J, Yates T, Singh AK, Davies MJ, Khunti K. The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis. Endocrinol Diabetes Metab. 2020. doi.org/10.1002/edm2.176.
CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected Underlying Health Conditions among patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:382–6.
NHS England » Type 1 and Type 2 diabetes. and COVID-19 related mortality in England. www.england.nhs.uk/publication/type-1-and-type-2-diabetes-and-covid-19-related-mortality-in-england/. Accessed 6 Jun 2021.
Zhu L, She Z-G, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31:1068–1077e3.
Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52:1193–4.
Council ERA-EDTA, Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2021;36:87–94.
Canada PHA. of (2020) Coronavirus disease (COVID-19): Prevention and risks. www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks.html. Accessed 6 Jun 2021.
Grupos de risco. In: SNS24. www.sns24.gov.pt/tema/doencas-infecciosas/covid-19/grupos-de-risco/. Accessed 6 Jun 2021.
Gonçalves DA, Ribeiro V, Gualberto A, Peres F, Luconi M, Gameiro J. (2021) COVID-19 and Obesity: An Epidemiologic Analysis of the Brazilian Data. Int J Endocrinol 2021:e6667135.
Kirillov Y, Timofeev S, Avdalyan A, Nikolenko VN, Gridin L, Sinelnikov MY. Analysis of risk factors in COVID-19 adult mortality in Russia. J Prim Care Community Health. 2021;12:21501327211008050.
Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, Kirmizis D, Schneditz D, Van Der Sande F, Mitra S. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;35:737–41.
Bridger JC. Raising awareness of acute kidney injury and chronic kidney disease in light of COVID-19. Br J Healthc Manag. 2022;28:82–9.
Galbadage T, Peterson BM, Awada J, Buck AS, Ramirez DA, Wilson J, Gunasekera RS. Systematic review and Meta-analysis of sex-specific COVID-19 clinical outcomes. Front Med. 2020. doi.org/10.3389/fmed.2020.00348.
Yassin A, Sabsigh R, Al-Zoubi RM, Aboumarzouk OM, Alwani M, Nettleship J, Kelly D. Testosterone and Covid-19: an update. Rev Med Virol. 2023;33:e2395.
Tang Fui M, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014;16:223.
Vasconcelos ICBDL, Prestes JYDN, Ribeiro RRS, Lima SJL, Farias SDCF, Barbosa LDDS, Vasconcelos AC, Duque MAA. Política nacional de atençao integral a saúde do homem e os desafios de sua implementação. Braz J Dev. 2019;5:16340–55.
Ramos DB das, Burlandy N, Dias L PC, et al. Propostas governamentais brasileiras de ações de prevenção e controle do sobrepeso e obesidade sob perspectiva municipal. Cad Saúde Pública. 2020. doi.org/10.1590/0102-311x00116519.
